Niagen Bioscience, Inc. (NASDAQ: NAGE)

Niagen Bioscience, Inc. operates in the health and wellness industry, specializing in the development, manufacturing, and distribution of products designed to enhance cellular health. The company focuses on leveraging scientific research to create innovative solutions that target aging and overall well-being. Its primary product, Tru Niagen, is a patented form of nicotinamide riboside (NRC), a compound known for its role in boosting levels of nicotinamide adenine dinucleotide (NAD+), a critical coenzyme for cellular energy and repair.

The company generates revenue through the sale of its consumer products and ingredients. Tru Niagen is marketed as a dietary supplement aimed at supporting cellular health, energy metabolism, and longevity. The product is sold directly to consumers and through distributors, catering to a global customer base interested in health and wellness. Additionally, Niagen Bioscience supplies food-grade NRC to third-party manufacturers for use in various health and wellness products.

• Consumer Products Segment: This segment includes the production and distribution of Tru Niagen, a dietary supplement designed to enhance cellular health. The product is marketed to consumers interested in improving energy levels, metabolic function, and overall well-being. The segment caters to a global market, with sales occurring through direct-to-consumer channels and distributors.

• Ingredients Segment: This segment focuses on the supply of food-grade NRC to third-party manufacturers. The company has a long-term supply agreement with W.R. Grace & Co.-Conn., which serves as its exclusive supplier of food-grade NRC. This segment caters to manufacturers in the health and wellness industry, providing them with high-quality ingredients for their products.

• Analytical Reference Standards and Services Segment: This segment involves the provision of analytical reference standards and services, which are used for quality control and research purposes. The segment caters to laboratories and research institutions, offering products and services that support scientific and regulatory compliance.

Niagen Bioscience operates in a competitive industry characterized by numerous players in the health and wellness sector. Key competitors include other companies developing and marketing NAD+ boosters and related supplements. The company's competitive advantages lie in its proprietary technology, strong intellectual property portfolio, and strategic partnerships with reputable suppliers. The company's focus on scientific research and development allows it to maintain a leadership position in the NAD+ enhancement market.

The company's customer base is diverse, encompassing individual consumers, distributors, and manufacturers. While specific customer names are not disclosed, the general customer base includes health-conscious individuals, wellness enthusiasts, and businesses in the health and wellness industry. The company's products are distributed globally, reaching a wide range of customers interested in improving their health and well-being.